NCT03907228View on ClinicalTrials.gov

Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis

NAUnknownINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

March 15, 2019

Primary Completion Date

April 30, 2020

Study Completion Date

May 31, 2020

Conditions
Dermatitis, Atopic
Interventions
DIETARY_SUPPLEMENT

RHT-3201

PROBIOTIC

Trial Locations (1)

Unknown

RECRUITING

Chung-Ang University Hospital, Seoul

Sponsors
All Listed Sponsors
lead

IlDong Pharmaceutical Co Ltd

INDUSTRY

NCT03907228 - Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter